CINECA IRIS Institutional Research Information System

CAPELLO, Michela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.966
EU - Europa 1.968
AS - Asia 1.876
Continente sconosciuto - Info sul continente non disponibili 207
SA - Sud America 174
AF - Africa 58
OC - Oceania 38
Totale 8.287
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.854
SG - Singapore 684
CN - Cina 618
IT - Italia 493
DK - Danimarca 237
SE - Svezia 222
VN - Vietnam 185
DE - Germania 141
IE - Irlanda 138
BR - Brasile 136
FR - Francia 128
AT - Austria 124
UA - Ucraina 110
FI - Finlandia 104
GB - Regno Unito 93
CA - Canada 63
KR - Corea 59
HK - Hong Kong 56
PL - Polonia 55
JP - Giappone 53
IN - India 51
TW - Taiwan 50
SN - Senegal 38
AU - Australia 37
NL - Olanda 24
ID - Indonesia 21
BE - Belgio 20
RU - Federazione Russa 20
IQ - Iraq 18
JM - Giamaica 15
CL - Cile 12
PK - Pakistan 12
TR - Turchia 12
UZ - Uzbekistan 12
BD - Bangladesh 11
BY - Bielorussia 11
ES - Italia 11
MX - Messico 10
RO - Romania 9
ZA - Sudafrica 9
AR - Argentina 8
EU - Europa 7
CH - Svizzera 5
CZ - Repubblica Ceca 5
EC - Ecuador 5
NI - Nicaragua 5
PH - Filippine 5
CO - Colombia 4
CR - Costa Rica 4
GT - Guatemala 4
MY - Malesia 4
DZ - Algeria 3
IL - Israele 3
JO - Giordania 3
PE - Perù 3
VE - Venezuela 3
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
CY - Cipro 2
EE - Estonia 2
GP - Guadalupe 2
GR - Grecia 2
HU - Ungheria 2
KE - Kenya 2
KG - Kirghizistan 2
MA - Marocco 2
MD - Moldavia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
BT - Bhutan 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
EG - Egitto 1
HN - Honduras 1
HR - Croazia 1
IM - Isola di Man 1
IR - Iran 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MT - Malta 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
UY - Uruguay 1
VG - Isole Vergini Britanniche 1
Totale 8.087
Salva come PNG Salva come JPEG
Città #
Chandler 400
Singapore 375
Ashburn 353
Ann Arbor 322
Beijing 305
San Jose 187
Wilmington 147
Santa Clara 144
Houston 139
Dublin 137
Dearborn 135
Vienna 122
Fairfield 114
Nyköping 83
Jacksonville 82
Woodbridge 70
Guangzhou 64
Seattle 61
Milan 52
Ho Chi Minh City 51
Cambridge 50
Los Angeles 49
Warsaw 49
Medford 48
Turin 47
Villeurbanne 45
Princeton 44
Torino 44
Hong Kong 43
Council Bluffs 42
The Dalles 41
Fremont 40
Hanoi 37
Lauterbourg 37
Columbus 36
Taipei 36
Dallas 34
Tokyo 34
Pisa 32
Rome 32
Redwood City 27
Boardman 26
Munich 26
Dong Ket 24
Orem 24
Shanghai 23
Phoenix 21
Buffalo 20
New York 20
Washington 19
Boston 18
Brussels 18
Norwalk 18
Helsinki 17
San Mateo 16
London 15
Nanjing 15
Toronto 14
Chengdu 13
Turku 13
Jakarta 12
Naples 12
Nuremberg 12
Seoul 12
Atlanta 11
Chennai 11
Chicago 11
Wuhan 11
Frankfurt am Main 10
Kingston 10
Manchester 10
Melbourne 10
Wayne 10
San Diego 9
Santiago 9
Shenyang 9
Zhengzhou 9
Baghdad 8
Bologna 8
Brooklyn 8
Falls Church 8
Haiphong 8
Lincoln 8
Montreal 8
Mumbai 8
Paris 8
Amsterdam 7
Figino 7
Halmstad 7
Provo 7
São Paulo 7
Falkenstein 6
Hefei 6
Heidelberg 6
Las Vegas 6
Calgary 5
Changchun 5
Da Nang 5
Denver 5
Düsseldorf 5
Totale 4.884
Salva come PNG Salva come JPEG
Nome #
Circulating Autoantibodies to Phosphorylated α-Enolase are a Hallmark of Pancreatic Cancer. 536
Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers 406
Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis 402
Phosphorylated alpha-enolase induces autoantibodies in HLA-DR8 pancreatic cancer patients and triggers HLA-DR8 restricted T-cell activation. 395
α-enolase: a promising therapeutic and diagnostic tumor target 325
Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest 319
Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer Patients 307
Chemotherapy effects on immune-complexes in pancreatic ductal adenocarcinoma patients serum 297
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models. 273
Proteomic data analysis of pancreatic cancer patient sera revealed how chemotherapy shapes the immunogenicity of developing tumors 266
An integrative transcriptomic analysis of glycolytic genes reveals distinct metabolic subtypes in pancreatic cancer 262
Three are better than one: plasminogen receptors as cancer theranostic targets. 231
Identification of Novel Tumor-Associated Antigens in Chronic Lymphocytic Leukemia (CLL) by Serological Proteome Analysis (SERPA) 215
IDENTIFICATION BY SEROLOGICAL PROTEOME ANALYSIS (SERPA) OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) 210
A Mouse To Human Autoantibody Signature in Pancreatic Ductal Adenocarcinoma 209
Autoantibody signature in human ductal pancreatic adenocarcinoma 195
Alpha-enolase elicits specific adenocarcinoma pancreatic-T cell responses in healthy donors and tumor patients 192
Abstract B49: Alpha-enolase knockdown reprograms metabolism and points out targetable pathways to counteract PDA growth 191
Identification and functional characterization of tumor specific antibody responses in chronic lymphocytic leukemia 182
IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF ANTIBODY IMMUNE RESPONSES ELICITED BY SELF ANTIGENS IN CHRONIC LYMPHOCYTIC LEUKEMIA 180
Serological Proteome Analysis (SERPA) as a tool for the identification of novel tumor antigens in chronic lymphocytic leukemia (CLL) 171
Identification by serological proteome analysis (SERPA) of tumor-associated antigens eliciting antibody-responses in chronic lymphocytic leukemia 168
SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THE IDENTIFICATION OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY-RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA 159
Identification by serological proteome analysis (SERPA) of novel tumor associated antigens in chronic lymphocytic leukemia (CLL) 158
Identification of tumor associated antigens in pancreatic cancer by serological proteome analysis 150
Expression of IFNgammaR2 mutated in a dileucine internalization motif reinstates IFNgamma signaling and apoptosis in human T lymphocytes 147
Identification of tumor associated antigens in pancreatic cancer by serological proteome analysis 145
Identification of tumor associated antigens in pancreatic cancer by serological proteome analysis (SERPA) 144
Mass spectrometry analysis reveals novel O-methylation of L-lactate dehydrogenase from pancreatic ductal adenocarcinoma cells 143
SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THEIDENTIFICATION OF NOVEL TUMOR-ASSOCIATED ANTIGENS INCHRONIC LYMPHOCYTIC LEUKEMIA 139
Serological proteome analysis (SERPA) as a tool for the identification of tumor antigens capable of eliciting immune responses in chronic lymphocytic leukemia (CLL) 138
QUARTZ CRYSTAL MICROBALANCE WITH DISSIPATION (QCM-D) AS TOOL TO EXPLOIT ANTIGEN-ANTIBODY INTERACTIONS IN PANCREATIC DUCTAL ADENOCARCINOMA DETECTION 137
Towards pancreatic cancer diagnosis using EIS biochips. 125
Mass spectrometry analysis of the post-translational modifications of alpha-enolase from pancreatic ductal adenocarcinoma cells 123
PHOSPHOPROTEOMIC ANALYSIS OF PANCREATIC DUCTAL ADENOCARCINOMA CELLS REVEALS DIFFERENTIAL PHOSPHORYLATION OF CELL ADHESION, CELL JUNCTION AND STRUCTURAL PROTEINS 117
A method and a kit for the in vitro diagnosis of pancreatic ductal adenocarcinoma or for determining the predisposition to pancreatic ductal adenocarcinoma 115
Proteomic Analysis Reveals Warburg Effect and Anomalous Metabolism of Glutamine in Pancreatic Cancer Cells 110
Proteomic Analysis of Pancreatic Ductal Adenocarcinoma Cells Reveals Metabolic Alterations. 108
Mass spectrometric analysis reveals O-methylation of pyruvate kinase from pancreatic cancer cells. 108
Procedimento e kit per la diagnosi in vitro dell’adenocarcinoma duttale pancreatico o per determinare la predisposizione all’adenocarcinoma duttale pancreatico 89
Totale 8.287
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.640
article - articoli 0
book - libri 0
conference - conferenze 9.820
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.460
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022553 0 0 0 35 22 35 57 32 23 58 168 123
2022/2023946 80 98 17 131 92 216 50 73 109 20 40 20
2023/2024334 62 51 30 20 10 57 4 29 2 12 19 38
2024/2025890 13 29 32 95 212 61 27 46 118 48 71 138
2025/20261.881 218 48 91 163 207 86 324 71 195 115 74 289
2026/2027450 76 121 177 76 0 0 0 0 0 0 0 0
Totale 8.287